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Abstract
Background: Current research focuses on cancer therapy, diagnostics and imaging, although many challenges still
need to be solved. However, for the application of gold nanoparticles (GNPs) in therapy and diagnostics it is
necessary to know the bioaccumulation and local or systemic toxicity associated to them. The aim of the present
study was to investigate the effects of intraperitoneal administration of GNPs on the histological alterations of the
heart tissue of rats in an attempt to cover and understand the toxicity and the potential role of GNPs in the
therapeutic and diagnostic applications.
Methods: Animals were randomly divided into 3 GNPs-treated rats groups and one control group (CG). The 10, 20 and
50 nm GNPs were administered intraperitonealy at the rate of 3 or 7 days as follows: Group 1: received infusion of 100
μl GNPs of size 10 nm for 3 or 7 days; Group 2: received infusion of 100 μl GNPs of size 20 nm for 3 or 7 days; Group 3:
received infusion of 100 μl GNPs of size 50 nm for 3 or 7 days. Control group: received no GNPs.
Results: In comparison with the respective control rats, GNPs-treated rat received 100 μl of 10 and 20 nm particles
for 3 days or 7 days demonstrating congested heart muscle with prominent dilated blood vessels, scattered and
extravasations of red blood cells, focus of muscle hyalinosis, disturbed muscle fascicles, dense prominent focus of
inflammatory cells infiltrate by small lymphocytes and few plasma cells while GNPs-treated rat received 100 μl of
50 nm particles for 3 or 7 days demonstrating benign normal looking heart muscle with normal muscle direction
and fascicles, and very few scattered small lymphocytes.
Conclusions: The histological alterations induced by intraperitoneal administration of GNPs were size-dependent
with smaller ones induced more affects and related with time exposure of GNPs. This study suggests that
interaction of GNPs with proteins and various cell types might be evaluated as part of the toxicological assessment
in addition to further experiments related to tissues antioxidant enzymes, oxidative parameters, lipid peroxidation,
production of free radicals and/or ROS and cytokine, histomorphologcal and ultrastrucural will be performed to
cover and understand the toxicity and the potential use of GNPs as therapeutic and diagnostic tool.
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Introduction
The NPs are being investigated for gene delivery pur-
poses [1-3] and cancer therapy [4]. Data concerning the
behavior and toxicity of particles mainly comes from
studies on inhaled NPs [5].
NPs may differ in reactivity and solubility and may inter-
act with all kinds of endogenous proteins, lipids, polysac-
charides and cells. A series of tests was proposed for
evaluation of the toxicity of NPs used in drug delivery sys-
tems [6]. GNPs can easily enter cells and the demonstra-
tion that amine and thiol groups bind strongly to GNPs
has enabled their surface modification with amino acids
and proteins for biomedical applications [7-9].Correspondence: abdelhalimmak@yahoo.com
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Gold in its bulk form has been considered an inert,
noble metal with some therapeutic and medicinal value.
GNPs are thought also to be relatively non-cytotoxic
[10] while the metallic nature of the metal derived NPs
and the presence of transition metals encourages the
production of reactive oxygen species (ROS) leading to
oxidative stress [9,11,12].
The use of NPs as drug carriers may reduce the toxi-
city of the incorporated drug [12]. There are differing
reports of the extent of the toxic nature of these parti-
cles owing to the different modifications of the GNPs,
surface functional attachments and shape and diameter
size of the NPs [13,14].
The particle size-dependent organ distribution of
GNPs has been studied in vivo [15-17]. In vivo studies
in rats exposed to aerosols of GNPs revealed that the
NPs were rapidly taken into the system with the highest
accumulation in the lungs, aorta, esophagus and olfac-
tory bulb [18].
In order to understand and categorize the mechanisms
for GNPs toxicity, histological data is needed on the
response of living systems to the presence of GNPs of
varying size, shape, surface, and exposure duration.
The histological and histochemical characterization of
the heart tissues due to GNPs has not been documented
and identified before. In the present study, an attempt
has been made to characterize the possible histological
alterations in the heart tissues after intraperitoneal
administration of GNPs and, if so, whether are related
to the size of these GNPs and the time of exposure.
Materials and methods
Gold nanoparticles
GNPs of different sizes (10, 20 and 50 nm; products
MKN-Au-010, MKN-Au-020 and MKN-Au-050,
Canada, respectively) were purchased. All GNPs used in
this study were in aqueous solution at a concentration
of 0.01%. The mean size and morphology of these GNPs
were evaluated from transmission electron microscope
(TEM) images.
Animals
A total of 40 healthy male Wistar-Kyoto rats were
obtained from the Laboratory Animal Center (College of
Pharmacy, King Saud University, Saudi Arabia). The rats
nearly of the same age (12 weeks old) and weighing
220-240 g of King Saud University colony were used.
Animals were randomly divided into 3 GNPs-treated
rats groups and one control group (CG). The 10, 20 and
50 nm GNPs were administered intraperitonealy at the
rate of 3 or 7 days as follows: Group 1: received infusion
of 100 μl GNPs of size 10 nm for 3 or 7 days (n = 10);
Group 2: received infusion of 100 μl GNPs of size 20
nm for 3 or 7 days (n = 10); Group 3: received infusion
of 100 μl GNPs of size 50 nm for 3 or 7 days (n = 10).
Control group: received no GNPs (n = 10).
The rats were maintained on standard laboratory
rodent diet pellets and housed in humidity and tempera-
ture-controlled ventilated cages on a 12 h day/night
cycle. All experiments were conducted in accordance
with the guidelines approved by King Saud University
Local Animal Care and Use Committee.
Fresh portions of the heart from each rat were cut
rapidly, fixed in neutral buffered formalin (10%), then
dehydrated, with grades of ethanol (70, 80, 90, 95 and
100%). Dehydration was then followed by clearing the
samples in 2 changes of xylene.
Samples were then impregnated with 2 changes of
molten paraffin wax, then embedded and blocked out.
Paraffin sections (4-5 um) were stained with hematoxy-
lin and eosin (the conventional histological stain)
according to Pearse [19]. The bright-field images were
acquired using a Nikon Eclipse 800 microscope
equipped with a Nikon DXM1200 color CCD camera
(Nikon Instruments Inc., Melville, NY). Stained sections
of control and treated rats were examined for histologi-
cal alterations in the heart tissues.
Results and discussions
Size and morphology of gold nanoparticles
The 10 and 20 nm GNPs show spherical shape while 50
nm GNPs show hexagonal shape. The mean size for
GNPs was calculated from the images taken by the
transmission electron microscope (TEM): The 10 nm
GNPs was of mean size 9.45 ± 1.33 nm, 20 nm GNPs
was of mean size 20.18 ± 1.80 and the 50 nm GNPs was
of mean size 50.73 ± 3.58 [20-23].
Histological alterations
No mortality occurred for the administration periods 3
and 7 days of GNPs in any of the experimental groups
of the present investigation, and no alterations were
observed in the appearance and behavior of GNPs trea-
ted rats in comparison with the control ones.
Control group (Figure 1): Microscopic pictures show
GNPs-normal rat demonstrating benign blunt looking
heart muscle of different heart muscle directions and
with no pathological findings.
In comparison with the control group, the following
histological alterations were detected in the heart tissue
of GNPs-treated rats. These histological alterations were
observed in Figures 2, 3, 4, 5, 6, 7 and can be summar-
ized as follows:
1) GNPs-treated rat received 100 μl of 10 nm particles
for 3 days demonstrating heart muscle with prominent
dilated congested blood vessels, scattered and extravasa-
tions of red blood cells and few small lymphocytic infil-
trate as shown in Figure 2
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2) GNPs-treated rat received 100 μl of 10 nm particles
for 7 days demonstrating scattered and extravasations of
red blood cells, congested dilated blood vessels, promi-
nent focus of small lymphocytic infiltrate, focus of mus-
cle hyalinosis, disturbed muscle fascicles as shown in
Figure 3.
3) GNPs-treated rat received 100 μl of 20 nm particles
for 3 days demonstrating dense prominent focus of
inflammatory cells infiltrate by small lymphocytes, few
plasma cells, prominent congested dilated blood vessels
and few scattered extravasations of red blood cells as
shown in Figure 4.
(40 x 8)        (100 x 2) 
Figure 1 GNPs-normal rat demonstrating normal heart muscle.
(40 x 4)      (40 x 5) 
    (100 x 1) 
Figure 2 GNPs-treated rat received 100 μl of 10 nm particles for 3 days demonstrating heart muscle with prominent dilated
congested blood vessels, scattered and extravasations of red blood cells and few small lymphocytic infiltrate.
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4) GNPs-treated rat received 100 μl of 20 nm particles
for 7 days demonstrating dense chronic inflammatory
cells infiltrate with extravasations of red blood cells as
shown in Figure 5.
5) GNPs-treated rat received 100 μl of 50 nm particles
for 3 days demonstrating benign normal looking heart
muscle with normal muscle direction and fascicles with
no pathological effect as shown in Figure 6
6) GNPs-treated rat received 100 μl of 50 nm particles
for 7 days demonstrating benign normal looking heart
muscle, very few scattered small lymphocytes as shown
in Figure 7.
(A: 40 x 7)      (B: 100 x 1) 
(C: 100 x 7)               (D: 100 x 8) 
(E: 100 x 9) 
Figure 3 GNPs-treated rat received 100 μl of 10 nm particles for 7 days demonstrating scattered and extravasations of red blood
cells, congested dilated blood vessels, prominent focus of small lymphocytic infiltrate associated with focus of muscle hyalinosis,
disturbed muscle fascicles and scattered red blood cells.
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(A: 100 x 1)           (B: 40 x 8) 
 
 
(C: 100 x 6) 
Figure 4 GNPs-treated rat received 100 μl of 20 nm particles for 3 days demonstrating dense prominent focus of inflammatory cells
infiltrate of small lymphocytes and few plasma cells and prominent congested dilated blood vessels and few scattered extravasation
red blood cells.
 
   
          (40 x 1)      (100 x 9) 
Figure 5 GNPs-treated rat received 100 μl of 20 nm particles for 7 days demonstrating dense chronic inflammatory cells infiltrate with
extravasation of red blood cells.
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The histological heart alterations induced by intraperi-
toneal administration of GNPs were size-dependent with
smaller ones induced more affects and related with time
exposure of GNPs.
This infiltration of GNPs was more prominent after 7
days of administration and in rats received 10 and 20
nm GNPs than those received 50 nm GNPs. The histo-
logical heart alterations may suggest that GNPs could
interfere with the antioxidant defense mechanism and
leading to reactive oxygen species (ROS) generation
which in turn may imitate an inflammatory response.
Inflammatory cells infiltration was seen in the portal
triads and the perioral zones of GNPs treated rats. The
infiltrate cells were mainly lymphocytes and plasma cells
[20-23].
GNPs were more strongly oxidizing as evidenced by
lipid peroxidation [24,25] as well as decreased neutral
red retention time (NRRT) and numbers of thiol-con-
taining proteins evident in electrophoretic separations.
Cadmium may displace iron or copper from metallopro-
teins leading to oxidative stress via the Fenton reaction
[26].
It has been reported that 5 nm GNPs caused signifi-
cantly greater oxidative stress and cytotoxicity effects
than larger ones [27-29]. The 5 nm GNPs have shown
to catalyze nitric oxide (NO) production from endogen-
ous S-nitroso adducts with thiol groups in blood serum.
NO reacts rapidly with superoxide producing peroxyni-
trite (ONOO-) which can interact with lipids, DNA, and
proteins via direct oxidative reactions or via indirect
 
    
 
(40 x 5)         (100 x 4) 
Figure 6 GNPs-treated rat received 100 μl of 50 nm particles for 3 days demonstrating benign normal looking heart muscle with
normal muscle direction and fascicles with no pathological effect.
   
 
(40 x 4)      (100 x 8) 
Figure 7 GNPs-treated rat received 100 μl of 50 nm particles for 7 days demonstrating benign normal looking heart muscle, very few
scattered small lymphocytes with no any other pathological effect.
Abdelhalim Lipids in Health and Disease 2011, 10:205
http://www.lipidworld.com/content/10/1/205
Page 6 of 9
radical-mediated damage [28]. ROS production could
result from the proportionately high surface area of
GNPs used in this investigation [30,31].
Several possible mechanisms of action for the toxicity
of particles including injury of epithelial tissue [31],
inflammation, and oxidative stress response [32,33]. At
the cellular level oxidative stress is considered to be of
importance [34,35]. Nanoparticle induced oxidative
stress responses in keratinocytes, macrophages and
blood monocytes after in vitro exposure [36,37].
NPs are nearly of same dimensions as some biological
molecules such as proteins and nucleic acids. Many of
these biomolecules consist of long macromolecular
chains which are folded and shaped by cooperative and
weak interaction between side groups. The GNPs may
intrude into these complex folded structures.
GNPs activate the phagocytic activity of the sinusoidal
cells by increasing the number of Kupffte cells to help
in removing the accumulated GNPs where lysosomes
are involved in the intracellular breakdown into small
metabolic products. The produced Kupffer cells hyper-
plasia might be correlated with the amount of injurious
to the hepatic tissue induced by GNPs intoxication and
represents a defense mechanism of detoxification. Kupf-
fer cell hyperplasia is contributed to hepatic oxidative
stress [20-23,38].
This scattered cytoplasmic vacuolization might indi-
cate toxicity effect that exhibited as a result of distur-
bances of membranes function which leads to massive
influx of water and Na+ due to GNPS effects. Cellular
swelling might be accompanied by leakage of lysosomal
hydrolytic enzymes that lead to cytoplasmic degenera-
tion and macromolecular crowding [39].
Fatty change was observed in some swelling hepato-
cytes of rats exposed to 100 μl of 10 nm GNPs and to
lesser extent in the ones exposed to larger particles.
This hepatic liposis was more prominent in rat exposed
to GNPs for 7 days than those received the treatment
for 3 days [20-23]. Hepatocytes fatty change might be
due to lipid peroxidation that leads to rough endoplas-
mic damage and detachment of the cytoplasmic lipopro-
tein which indicate abnormal fat metabolism [22,25-27].
The rats received 10 and 20 nm GNPs showed hemor-
rhage and excess extravasation of red blood cells. Less
disruption was observed in rats exposed to 50 nm GNPs
while more damage was detected after 7 days than 3
days of GNPs exposure. This alteration might indicate
heart muscle damage and congestion by GNPs exposure.
None of the above alterations were observed in the
heart muscle of any member of the control group.
The interaction of NPs with living systems is also
affected by the characteristic dimensions. As noted
above, GNPs, of smaller size, may reach inside biomole-
cules, a situation not possible for larger GNPs. It has
been reported that inhaled NPs reach the blood and
may reach other target sites such as the liver, heart or
blood cells [40,41].
Reduction in size results in an enormous increase of
surface to volume ratio, so relatively more molecules of
the chemical are present on the surface, thus enhancing
the intrinsic toxicity. This may be one of the reasons
that smaller GNPs are generally more toxic than larger
particles of the same insoluble material when compared
on a mass dose base [42].
In the present study we have not measured GNPs
concentration in urine and feces, but this point will be
taken into our consideration in other new additional
experiments.
Further experiments related to tissues antioxidant
enzymes, oxidative parameters, lipid peroxidation, pro-
duction of free radicals and/or ROS and cytokine, histo-
morphologcal and ultrastrucural will be performed to
cover and understand the toxicity and the potential use
of GNPs as therapeutic and diagnostic tool.
Conclusions
In comparison with the respective control rats, histologi-
cal alterations induced in the heart tissue exposure
could be an indication of congested heart muscle with
dilated blood vessels, extravasations of red blood cells,
muscle hyalinosis, disturbed muscle fascicles, inflamma-
tory cells infiltrate by small lymphocytes and plasma
cells due to GNPs toxicity that became unable to deal
with the accumulated residues resulting from metabolic
and structural disturbances caused by these particles.
One might conclude that these alterations are size-
dependent with smaller ones induced more damage with
relation to the time exposure of GNPs.
The GNPs-treated rat received 100 μl of 50 nm parti-
cles for 3 or 7 days demonstrating benign normal look-
ing heart muscle with normal muscle direction and
fascicles, very few scattered small lymphocytes, and with
no other pathological effects.
One mechanism of toxicity of NPs is likely to be
induction of ROS and the consequential oxidative stress
in cells and organs. The appearance of congested heart
muscle with prominent dilated blood vessels and focus
of inflammatory cells infiltrate by small lymphocytes
and plasma cells may suggest that GNPs interact with
proteins and enzymes of the hepatic tissue interfering
with the antioxidant defense mechanism and leading to
reactive oxygen species (ROS) generation which in turn
may induce stress.
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